Introducing Data Mapper™: Revolutionizing Clinical Study Document Mapping through AI
Clymb Clinical has proudly announced the release of Data Mapper™, an innovative AI-driven platform designed to streamline the complex processes of SDTM and ADaM mapping. As a crucial part of the expanding Clymbr Hub™ ecosystem, this tool is set to revolutionize the way statistical programmers handle clinical study documents and metadata. Data Mapper™ allows professionals to easily ingest a variety of clinical study documents such as Protocol, CRF, SAP, EDC, and external data. The platform automatically generates CDISC SDTM mapping specifications and ADaM derivation frameworks, which are essential for clinical reporting and regulatory compliance.
The intuitive design of Data Mapper™ promotes collaboration among programmers and stakeholders, enabling them to review, refine, and manage mapping specifications in real time. This is especially beneficial as it accelerates one of the most time-consuming tasks in clinical study workflows. With Data Mapper™, the process of transforming study metadata into draft SDTM and ADaM specifications is significantly streamlined, leading to faster completion and improved accuracy.
Once the mapping specifications are finalized, the platform's advanced AI-powered code generator can produce production-ready SAS or R programs that align with the defined logic. This greatly reduces the manual programming effort required and promotes consistency across different clinical studies. Built on the same metadata-driven foundation as Clymb's flagship TFL Designer™ platform, Data Mapper™ supports standards reuse and cross-study scalability, facilitating seamless integration into broader automation workflows.
The introduction of Data Mapper™ marks an important step toward Clymb's vision of achieving true end-to-end automation in clinical reporting. Currently, clients using the Clymbr Hub can automate their biostatistics and statistical programming workflows from EDC data ingestion through to SDTM/ADaM generation and CSR assembly.
Clymb Clinical emphasizes its commitment to a future characterized by metadata-driven, standards-connected, and AI-assisted statistical programming. Bhavin Busa, Co-Founder of Clymb Clinical, expressed confidence that Data Mapper™ will help advance the clinical research industry toward a more automated and interoperable future. His vision aligns with the principles of the CDISC 360i initiative, which aims to establish a metadata-driven ecosystem for clinical data.
The tool has already gained traction among early adopters, with a production launch planned for July 2026. Interested professionals can learn more or join the early adopter program by contacting Clymb Clinical directly. Additionally, team members will be available to discuss Data Mapper™ at the upcoming PharmaSUG conference scheduled May 30–June 2 in Boston, MA.
Overall, Data Mapper™ is poised to be a game-changer for those involved in the clinical research field, providing new efficiencies and capabilities that were previously inaccessible. Its integration with the CDISC Library API will allow for dynamic consumption of standards metadata from CDISC sources, supporting enhanced consistency and automation across study workflows.
In an industry where precision and speed are paramount, the launch of Data Mapper™ signals a significant advancement in how clinical data is processed and analyzed. As the landscape of clinical trials continues to evolve, tools like Data Mapper™ are essential for keeping pace with the demands and expectations of modern clinical research.
The intuitive design of Data Mapper™ promotes collaboration among programmers and stakeholders, enabling them to review, refine, and manage mapping specifications in real time. This is especially beneficial as it accelerates one of the most time-consuming tasks in clinical study workflows. With Data Mapper™, the process of transforming study metadata into draft SDTM and ADaM specifications is significantly streamlined, leading to faster completion and improved accuracy.
Once the mapping specifications are finalized, the platform's advanced AI-powered code generator can produce production-ready SAS or R programs that align with the defined logic. This greatly reduces the manual programming effort required and promotes consistency across different clinical studies. Built on the same metadata-driven foundation as Clymb's flagship TFL Designer™ platform, Data Mapper™ supports standards reuse and cross-study scalability, facilitating seamless integration into broader automation workflows.
The introduction of Data Mapper™ marks an important step toward Clymb's vision of achieving true end-to-end automation in clinical reporting. Currently, clients using the Clymbr Hub can automate their biostatistics and statistical programming workflows from EDC data ingestion through to SDTM/ADaM generation and CSR assembly.
Clymb Clinical emphasizes its commitment to a future characterized by metadata-driven, standards-connected, and AI-assisted statistical programming. Bhavin Busa, Co-Founder of Clymb Clinical, expressed confidence that Data Mapper™ will help advance the clinical research industry toward a more automated and interoperable future. His vision aligns with the principles of the CDISC 360i initiative, which aims to establish a metadata-driven ecosystem for clinical data.
The tool has already gained traction among early adopters, with a production launch planned for July 2026. Interested professionals can learn more or join the early adopter program by contacting Clymb Clinical directly. Additionally, team members will be available to discuss Data Mapper™ at the upcoming PharmaSUG conference scheduled May 30–June 2 in Boston, MA.
Overall, Data Mapper™ is poised to be a game-changer for those involved in the clinical research field, providing new efficiencies and capabilities that were previously inaccessible. Its integration with the CDISC Library API will allow for dynamic consumption of standards metadata from CDISC sources, supporting enhanced consistency and automation across study workflows.
In an industry where precision and speed are paramount, the launch of Data Mapper™ signals a significant advancement in how clinical data is processed and analyzed. As the landscape of clinical trials continues to evolve, tools like Data Mapper™ are essential for keeping pace with the demands and expectations of modern clinical research.
Topics Consumer Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.